Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
3.290
+0.150 (4.78%)
At close: Feb 13, 2026, 4:00 PM EST
3.300
+0.010 (0.30%)
After-hours: Feb 13, 2026, 4:27 PM EST

Cellectar Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
12.5523.299.5619.8735.757.17
Cash & Short-Term Investments
12.5523.299.5619.8735.757.17
Cash Growth
-63.36%143.48%-51.85%-44.36%-37.54%438.55%
Prepaid Expenses
1.070.960.890.660.870.77
Total Current Assets
13.6224.2510.4520.5336.5757.94
Property, Plant & Equipment
0.981.191.590.980.550.64
Other Long-Term Assets
0.030.030.030.080.080.08
Total Assets
14.6325.4712.0821.5937.258.66
Accounts Payable
4.014.119.182.561.411.43
Accrued Expenses
-3.48-2.912.442.01
Current Portion of Leases
0.10.080.060.050.140.12
Other Current Liabilities
0.81.7216.125.98--
Total Current Liabilities
4.919.3925.3611.53.993.56
Long-Term Leases
0.340.410.490.550.170.3
Total Liabilities
5.259.825.8512.054.163.86
Common Stock
000000
Additional Paid-In Capital
271.31261.12182.92168.14182.56161.53
Retained Earnings
-263.84-247.34-202.76-159.99-150.9-126.78
Total Common Equity
7.4813.77-19.848.1531.6634.76
Shareholders' Equity
9.3815.68-13.789.5433.0554.79
Total Liabilities & Equity
14.6325.4712.0821.5937.258.66
Total Debt
0.430.490.550.60.30.42
Net Cash (Debt)
12.1222.799.0119.2635.456.74
Net Cash Growth
-64.08%152.94%-53.22%-45.59%-37.61%462.53%
Net Cash Per Share
6.2818.4122.1281.90191.31859.21
Filing Date Shares Outstanding
4.241.541.080.320.20.17
Total Common Shares Outstanding
3.191.540.690.310.20.15
Working Capital
8.7114.86-14.919.0332.5854.38
Book Value Per Share
2.348.97-28.6926.06155.46229.47
Tangible Book Value
7.4813.77-19.848.1531.6634.76
Tangible Book Value Per Share
2.348.97-28.6926.06155.46229.47
Machinery
---0.80.580.45
Leasehold Improvements
---0.310.310.31
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q